The role of ETV6 in T-cell acute lymphoblastic leukemia
The role of ETV6 in T-cell acute lymphoblastic leukemia
批准号:
8608504
负责人:
Adolfo A. Ferrando
金额:
$32.2万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-02-01 至 2018-01-31
关键词:
AccountingAcute T Cell LeukemiaAddressAdultAdult Acute Lymphocytic LeukemiaAffinity ChromatographyC-terminalCell ProliferationCell physiologyChildhoodComplexDevelopmentDisease ProgressionDominant-Negative MutationETV6 geneEZH2 geneEarly treatmentFamilyGene Expression ProfileGeneticGenomicsGoalsHematopoieticHematopoietic stem cellsHumanInduced MutationLesionMediatingMolecularMusMutateMutationN-terminalNOTCH1 geneOncogenesOncogenicPathogenesisPathway interactionsPharmaceutical PreparationsPlayProtein IsoformsProteinsProteomicsRUNX1 geneRecurrenceRefractory DiseaseRelapseResearchResearch ProposalsRoleSamplingSomatic MutationStem cellsT-Cell TransformationT-LymphocyteTestingTranscription Repressor/CorepressorTranscriptional RegulationTransferaseTransgenic MiceTreatment FailureTumor Suppressor GenesTumor Suppressor Proteinsbonechemotherapygenetic analysisin vivoinsightleukemialoss of function mutationmutantmutant mouse modelnoveloutcome forecastprogenitorprogramspublic health relevanceresponsestemt(821)(q22q22)tooltumor
中文摘要
描述(申请人提供):该项目旨在建立T细胞急性淋巴细胞白血病(T-ALL)中ETV6突变激活的致癌机制。我们的中心假设是,在T-ALL中发现的ETV6突变导致显性阴性ETV6亚型的表达,其表达扰乱了控制T细胞祖细胞中细胞增殖、分化和存活的特定转录调控网络。此外,我们认为ETV6突变与激活突变在T-ALL中EZH2的功能缺失和缺失中具有协同作用。因此,这项研究的目标是确定ETV6突变诱导的T-ALL的转录程序和致癌途径。为了实现这些目标,我们建议:(I)定义突变ETV6在T-ALL中控制的转录程序;以及(Iii)使用突变ETV6诱导T-ALL的小鼠模型来分析突变ETV6诱导转化的遗传学。
英文摘要
DESCRIPTION (provided by applicant): This project aims to establish the oncogenic mechanisms activated by ETV6 mutations in T- cell acute lymphoblastic leukemia (T-ALL). Our central hypothesis is that ETV6 mutations found in T- ALL result in expression of dominant negative ETV6 isoforms whose expression disrupts specific transcriptional regulatory networks that control cell proliferation, differentiation and survival in T-cell progenitor cells. In additin, we propose that ETV6 mutations cooperate with activating mutations in loss of function mutations and deletions in EZH2 in T-ALL. Thus, the goals of this research proposal are to define the transcriptional programs and oncogenic pathways responsible for the pathogenesis of mutant ETV6 induced T-ALL. To achieve these objectives we propose: (i) to define the transcriptional program controlled by mutant ETV6 in T-ALL; and (iii) to analyze the genetics of mutant ETV6 induced transformation using a mouse models of mutant ETV6 induced T-ALL.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of PHF6 in the control of hematopoietic stem cell aging.
-
批准号:10280176
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2021
-
负责人:Adolfo A. Ferrando
-
依托单位:
Molecular characterization and targeting of NT5C2 mutations in acute lymphoblastic leukemia
-
批准号:10221633
-
项目类别:
-
资助金额:$38.35万
-
财政年份:2017
-
负责人:Adolfo A. Ferrando
-
依托单位:
Molecular pathways and targeted therapies in human leukemia
-
批准号:10224720
-
项目类别:
-
资助金额:$96.0万
-
财政年份:2017
-
负责人:Adolfo A. Ferrando
-
依托单位:
Molecular pathways and targeted therapies in human leukemia
-
批准号:9981678
-
项目类别:
-
资助金额:$100.49万
-
财政年份:2017
-
负责人:Adolfo A. Ferrando
-
依托单位:
Molecular pathways and targeted therapies in human leukemia
-
批准号:9390282
-
项目类别:
-
资助金额:$84.93万
-
财政年份:2017
-
负责人:Adolfo A. Ferrando
-
依托单位:
Molecular characterization and targeting of NT5C2 mutations in acute lymphoblastic leukemia
-
批准号:9750649
-
项目类别:
-
资助金额:$37.12万
-
财政年份:2017
-
负责人:Adolfo A. Ferrando
-
依托单位:
Molecular pathways and targeted therapies in human leukemia
-
批准号:9752494
-
项目类别:
-
资助金额:$93.12万
-
财政年份:2017
-
负责人:Adolfo A. Ferrando
-
依托单位:
The role of ETV6 in T-cell acute lymphoblastic leukemia
-
批准号:8997463
-
项目类别:
-
资助金额:$33.2万
-
财政年份:2013
-
负责人:Adolfo A. Ferrando
-
依托单位:
The role of ETV6 in T-cell acute lymphoblastic leukemia
-
批准号:9204814
-
项目类别:
-
资助金额:$33.2万
-
财政年份:2013
-
负责人:Adolfo A. Ferrando
-
依托单位:
The role of ETV6 in T-cell acute lymphoblastic leukemia
-
批准号:8421646
-
项目类别:
-
资助金额:$33.2万
-
财政年份:2013
-
负责人:Adolfo A. Ferrando
-
依托单位:
The role of PHF6 in T-cell acute lymphoblastic leukemia
-
批准号:8588789
-
项目类别:
-
资助金额:$32.2万
-
财政年份:2010
-
负责人:Adolfo A. Ferrando
-
依托单位:
The role of PHF6 in T-cell acute lymphoblastic leukemia
-
批准号:8204479
-
项目类别:
-
资助金额:$33.2万
-
财政年份:2010
-
负责人:Adolfo A. Ferrando
-
依托单位:
The role of PHF6 in T-cell acute lymphoblastic leukemia
-
批准号:8386667
-
项目类别:
-
资助金额:$31.21万
-
财政年份:2010
-
负责人:Adolfo A. Ferrando
-
依托单位:
The role of PHF6 in T-cell acute lymphoblastic leukemia
-
批准号:8034137
-
项目类别:
-
资助金额:$33.32万
-
财政年份:2010
-
负责人:Adolfo A. Ferrando
-
依托单位:
Mechanisms of T-cell leukemogenesis induced by NOTCH1
-
批准号:7816499
-
项目类别:
-
资助金额:$53.36万
-
财政年份:2009
-
负责人:Adolfo A. Ferrando
-
依托单位:
The role of AKT signaling in NOTCH1 induced leukemias
-
批准号:7465798
-
项目类别:
-
资助金额:$34.08万
-
财政年份:2008
-
负责人:Adolfo A. Ferrando
-
依托单位:
The role of AKT signaling in NOTCH1 induced leukemias
-
批准号:7755824
-
项目类别:
-
资助金额:$33.72万
-
财政年份:2008
-
负责人:Adolfo A. Ferrando
-
依托单位:
The role of AKT signaling in NOTCH1 induced leukemias
-
批准号:8208191
-
项目类别:
-
资助金额:$32.46万
-
财政年份:2008
-
负责人:Adolfo A. Ferrando
-
依托单位:
GENOMICS TECHNOLOGIES RESOURCE
-
批准号:7669916
-
项目类别:
-
资助金额:$5.88万
-
财政年份:2008
-
负责人:Adolfo A. Ferrando
-
依托单位:
The role of AKT signaling in NOTCH1 induced leukemias
-
批准号:8013883
-
项目类别:
-
资助金额:$32.46万
-
财政年份:2008
-
负责人:Adolfo A. Ferrando
-
依托单位:
海外基金